PT  - JOURNAL ARTICLE
AU  - Rachael Moses
TI  - The use of MI-E as a cost effective admission avoidance strategy for patients with advanced neuromuscular disease
DP  - 2014 Sep 01
TA  - European Respiratory Journal
PG  - P4300
VI  - 44
IP  - Suppl 58
4099  - http://erj.ersjournals.com/content/44/Suppl_58/P4300.short
4100  - http://erj.ersjournals.com/content/44/Suppl_58/P4300.full
SO  - Eur Respir J2014 Sep 01; 44
AB  - Increasing hospital admissions for patients with advanced neuromuscular disease and continued pressure on acute medical beds have encouraged the development of interventions to keep patients at home. In 2011/12 an audit of unplanned neuromuscular admissions across four UK regions showed that 40% acute admissions were avoidable (1). The development of community services have enabled mechanical insuffulation-exsuffulation (MI-E) devices to be used at home.Objective:To assess the feasibility of providing MI-E on hospital discharge as an admission avoidance tool for patients with advanced neuromuscular disease and repeated hospital admissions for aspiration pneumonia.Methods: Three individual case studies investigating the effectiveness of providing an MI-E device (NIPPY Clearway) on hospital discharge for neuromuscular patients (not requiring ventilation) with repeated hospital admissions.Results:View this table:Conclusion:The provision of a MI-E device for patients with neuromuscular disease can prevent future hospital admissions and is therefore a cost effective admission avoidance strategy. Patients should be offered MI-E devices as part of a planned discharge package.References1.Unplanned admissions of neuromuscular patients. NHS Audit Unit 2012.2. Department of health https://www.gov.uk/government/2011-12-reference-costs-publication.pdf.